PDF
Full
Outline
Non-small cell lung cancer (NSCLC) constitutes the largest portion of lung cancer overall, with high incidence and mortality rates. Apoptosis, is a hot focus in the clinical treatment of NSCLC, its main pathways include the extrinsic death receptor pathway, intrinsic mitochondrial apoptosis pathway and endoplasmic reticulum stress pathway, collectively regulating the cellular apoptosis process. Traditional Chinese medicine (TCM) has significant efficacy in the treatment and prognosis of NSCLC, with advantages such as boosting the body’s resistance and less adverse drug reactions. Studies have shown that various individual Chinese herbal medicines and compound formulas can treat NSCLC through the apoptosis pathway, alleviating the adverse drug reaction of radiotherapy and chemotherapy. Based on this, this article summarizes recent domestic and international literature, focusing on apoptosis, to summarize the research progress of TCM in treating NSCLC by regulating apoptosis, aiming to provide reference for clinical treatment for NSCLC.
PDF
0
0
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62199257
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
